glp-1 drug shortages GLP-1s Going Direct, How Novo
Description
Ozempic is contraindicated in patients with a family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
CS_00375/CEF0057
Tirzepatide (the main component in Mounjaro) is approved for the treatment of obesity, however, when used for weight control the company that makes it (Lilly) calls it Zepbound
Buttons remain thumb-friendly, search is responsive, and crashes were rare in my tests
